Pregled bibliografske jedinice broj: 970417
Products of advanced glycotionin patients with type 2 diabetes and vascular desease
Products of advanced glycotionin patients with type 2 diabetes and vascular desease // Annals of clinical biochemistry, 40 (2003), 5; 552-559 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 970417 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Products of advanced glycotionin patients with type 2 diabetes and vascular desease
Autori
Turk Z. ; Šesto M. ; Sklodar J. ; Ferenčak G. ; Pokupec R. ; Turk N. ; Stavljenić Rukavina A.:
Izvornik
Annals of clinical biochemistry (0004-5632) 40
(2003), 5;
552-559
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
advanced glycation ; type 2 diabetes ; vascular disease
Sažetak
Background: Non-enzymatic glycation leading to advanced glycation endproduct (AGE) formation is thought to contribute to vascular pathology. In the present study, AGEs and anti-AGE antibodies in free and immune complex-bound form were assayed in the serum of diabetic (DMCAD) (n = 69) and nondiabetic (n = 78) patients with coronary artery disease (CAD) and in control subjects (n = 47) free from vascular disease. Methods: A blocking enzyme-linked immunosorbent assay (ELISA) was used to test immunoreactivity against AGE epitope(s) and a competitive ELISA was used to measure total AGE content. Results: Anti-AGE immunoreactivity was significantly higher in diabetic than in control subjects (P = 0.045). Although a wide range of anti-AGE antibody titres were observed in nondiabetic CAD patients, there was no significant difference from those of control subjects. Both diabetic and nondiabetic CAD patients had a higher concentration of circulating immune complexes containing the AGE moiety as antigen than did control subjects (DMCAD versus control, P = 0.041 ; CAD versus control, P = 0.047). Study patients showed a positive correlation between serum AGE and AGE- immune complexes (DM, r = 0.29, P = 0.014 ; CAD, r = 0.26, P = 0.019), whereas no such correlation was recorded in controls (r = 0.08, P = 0.89). Conclusion: To our knowledge, this is the first study demonstrating increased AGE- immune complexes in patients with CAD, either with or without diabetes, suggesting that AGE- immune complexes might be involved in the atherosclerotic process, either as the result of it or as part of the pathophysiologic process.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Sveučilište Libertas
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE